Representational image for the novel coronavirus test | Photo: PTI
Representational image for the novel coronavirus test | Photo: PTI
Text Size:

London: A coronavirus antibody test backed by the U.K. government was 98.6% accurate in secret human trials held last month, the Telegraph reports.

The fingerprick test can tell within 20 minutes if a person has been exposed to the virus. It is developed by Oxford University together with U.K. diagnostics companies, a partnership set up by the government after a consignment of Chinese-made fingerprick tests proved largely useless, the newspaper said.

Thousands of prototypes have been manufactured in the U.K. ahead of regulatory approval, expected in coming weeks. The government is making plans to distribute tests to health-care professionals first before making them available for people to use at home. Current U.K.-approved tests involve sending blood samples to laboratories for analysis, a process that can take days.

This comes as scientists at King’s College London identified six different types of coronavirus using artificial intelligence software that revealed clusters of symptoms, the Telegraph said in a separate report. These findings are likely to help doctors spot the highest-risk patients.- Bloomberg


Also read: King’s College attempts to predict need for oxygen support with 6 ‘clusters’ of Covid patients


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

Share Your Views

LEAVE A REPLY

Please enter your comment!
Please enter your name here